Safety and tolerability of once-daily umeclidinium/vilanterol 125/25 mcg and umeclidinium 125 mcg in patients with chronic obstructive pulmonary disease: results from a 52-week, randomized, double-blind, placebo-controlled study
Crossref DOI link: https://doi.org/10.1186/1465-9921-15-78
Published Online: 2014-07-11
Published Print: 2014-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Donohue, James F
Niewoehner, Dennis
Brooks, Jean
O’Dell, Dianne
Church, Alison
Article History
Received: 12 February 2014
Accepted: 4 July 2014
First Online: 11 July 2014